CSI Market
Sign In | Register

Crescent Biopharma Inc (CBIO) Annual Balance Sheets

Annual · GAAP · USD millions
Access CBIO quarterly Balance Sheets →
This page allows investors to track Crescent Biopharma Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent213.19
Restricted Cash and Cash Equivalents, Current0.00
Cash & Short-term Investments213.00
Accounts receivable18.00
Prepaid Expense And Other Assets Current5.46
Total Current Assets236.66
Equipment/Property/Plant Net0.85
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent2.79
Operating Lease Right Of Use Asset1.47
Total Assets240.29
Liabilities
Accounts Payable, Current AC10.00
Accrued Liabilities, Current0.00
Other Liabilities, Current26.08
Total Current Liabilities36.07
Total Long-term Debt0.00
Other liabilities, Noncurrent1.21
Accrued Expenses And Other Accrued Liabilities Current16.34
Operating Lease Liability Noncurrent1.21
Total Liabilities37.28
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock370.79
Retained Earnings / Accumulated Deficit-171.81
Other Equity0.00
Common Stockholder's Equity199.01
Preferred Stockholder's Equity4.00
Total Stockholder's Equity203.01
Liabilities & Stockholder's Equity240.29
4 historic quarters locked

Sign in to unlock the full Crescent Biopharma Inc balance sheet history.

Sign In Create Free Account

About Crescent Biopharma Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: cbio-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-011983

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License